BACKGROUND: Two-thirds partial hepatectomy (PHx) is an established model for the study of liver regeneration after resection. This process is accompanied by oxidative stress. AIMS: In our study, we tested the effect of epigallocatechin gallate (EGCG), a green tea antioxidant, on the early phase of liver regeneration after PHx. METHODS: Male Wistar rats were divided into five groups: (I) laparotomy + water for intraperitoneal injections, (II) laparotomy + EGCG 50 mg/kg body weight, (III) PHx + water for injections, (IV) PHx + EGCG 20 mg/kg and (V) PHx + EGCG 50 mg/kg, for 3 consecutive days. The rats were killed 24 h after surgery. Biochemical analysis of rat sera was performed. Histological samples were stained with hematoxylin & eosin and bromodeoxyuridine (BrdU). In hepatectomized rats, we also measured plasma malondialdehyde, tissue malondialdehyde, glutathione and cytokines levels, the activity of caspases 3/7, expression of Nqo-1 and HO-1 genes at the mRNA level, and expression of p21, p-p27 and p-p53 genes at the protein level. RESULTS: We observed lower accumulation of BrdU in group V when compared to groups III and IV. The activity of caspases 3/7 and expression of p-p53 were lower in group V than in groups III and IV. Tissue levels of IL-6 were lower in group V when compared to group III. Significant differences were not noted in other parameters. CONCLUSIONS: Administration of EGCG did not stimulate early phase liver regeneration in rats after PHx. There was even lower DNA synthesis in the group treated with a high dose of EGCG.

Department of Physiology Faculty of Medicine in Hradec Kralove Charles University Prague Simkova 870 500 38 Hradec Kralove 1 Czech Republic

Zobrazit více v PubMed

Llovet JM, Di Bisceglie AM, Bruix J, et al. Panel of experts in HCC-design clinical Trials. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst. 2008;21:698–711. doi: 10.1093/jnci/djn134. PubMed DOI

Bramhall SR, Gur U, Coldham C, et al. Liver resection for colorectal metastases. Ann R Coll Surg Engl. 2003;85:334–339. doi: 10.1308/003588403769162468. PubMed DOI PMC

Bahde R, Spiegel HU. Hepatic ischaemia–reperfusion injury from bench to bedside. Br J Surg. 2010;97:1461–1475. doi: 10.1002/bjs.7176. PubMed DOI

Francés D, Ronco MT, Ochoa E, et al. Oxidative stress in primary culture hepatocytes isolated from partially hepatectomized rats. Can J Physiol Pharmacol. 2007;85:1047–1051. doi: 10.1139/Y07-087. PubMed DOI

Han SY, Chang EJ, Choi HJ, et al. Total antioxidant status and oxygen free radicals during hepatic regeneration. Transpl Proc. 2006;38:2214–2215. doi: 10.1016/j.transproceed.2006.07.017. PubMed DOI

Abu-Amara M, Gurusamy K, Hori S, Glantzounis G, Fuller B, Davidson BR. Systematic review of randomized controlled trials of pharmacological interventions to reduce ischaemia-reperfusion injury in elective liver resection with vascular occlusion. HPB (Oxford) 2010;12:4–14. doi: 10.1111/j.1477-2574.2009.00120.x. PubMed DOI PMC

Higgins GM, Anderson RM. Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol. 1931;12:186–202.

Beyer TA, Xu W, Teupser D, et al. Impaired liver regeneration in Nrf2 knockout mice: role of ROS-mediated insulin/IGF-1 resistance. EMBO J. 2008;27:212–223. doi: 10.1038/sj.emboj.7601950. PubMed DOI PMC

Surh YJ, Kundu JK, Na HK. Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med. 2008;74:1526–1539. doi: 10.1055/s-0028-1088302. PubMed DOI

Jung KA, Kwak MK. The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules. 2010;15:7266–7291. doi: 10.3390/molecules15107266. PubMed DOI PMC

Ronco MT, deAlvarez ML, Monti J, et al. Modulation of balance between apoptosis and proliferation by lipid peroxidation (LPO) during rat liver regeneration. Mol Med. 2002;8:808–817. PubMed PMC

Dinkova-Kostova AT, Talalay P. Direct and indirect antioxidant properties of inducers of cytoprotective proteins. Mol Nutr Food Res. 2008;52:S128–S138. PubMed

Lambert JD, Elias RJ. The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Arch Biochem Biophys. 2010;501:65–72. doi: 10.1016/j.abb.2010.06.013. PubMed DOI PMC

Chen C, Yu R, Owuor ED, Kong AN. Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch Pharm Res. 2000;23:605–612. doi: 10.1007/BF02975249. PubMed DOI

Chen JH, Tipoe GL, Liong EC, et al. Green tea polyphenols prevent toxin-induced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants. Am J Clin Nutr. 2004;80:742–751. PubMed

Yasuda Y, Shimizu M, Sakai H, et al. (−)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRβ and IGF-1R. Chem Biol Interact. 2009;10:159–164. doi: 10.1016/j.cbi.2009.07.015. PubMed DOI

Tipoe GL, Leung TM, Liong EC, Lau TY, Fung ML, Nanji AA. Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4) induced liver injury in mice. Toxicology. 2010;29:45–52. doi: 10.1016/j.tox.2010.04.014. PubMed DOI

Fiorini RN, Donovan JL, Rodwell D, et al. Short-term administration of (−)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice. Liver Transpl. 2005;11:298–308. doi: 10.1002/lt.20348. PubMed DOI

Kuzu N, Bahcecioglu IH, Dagli AF, Ozercan IH, Ustündag B, Sahin K. Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet. J Gastroenterol Hepatol. 2008;23:e465–e470. doi: 10.1111/j.1440-1746.2007.05052.x. PubMed DOI

Chung MY, Park HJ, Manautou JE, Koo SI, Bruno RS. Green tea extract protects against nonalcoholic steatohepatitis in ob/ob mice by decreasing oxidative and nitrative stress responses induced by proinflammatory enzymes. J Nutr Biochem. 2012;23:361–367. doi: 10.1016/j.jnutbio.2011.01.001. PubMed DOI PMC

Giakoustidis DE, Giakoustidis AE, Iliadis S, et al. Attenuation of liver ischemia/reperfusion induced apoptosis by epigallocatechin-3-gallate via down-regulation of NF-kappaB and c-Jun expression. J Surg Res. 2010;159:720–728. doi: 10.1016/j.jss.2008.08.038. PubMed DOI

Wolfram S, Raederstorff D, Preller M, et al. Epigallocatechin gallate supplementation alleviates diabetes in rodents. J Nutr. 2006;136:2512–2518. PubMed

Collins QF, Liu HY, Pi J, Liu Z, Quon MJ, Cao W. Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5′-AMP-activated protein kinase. J Biol Chem. 2007;12:30143–30149. doi: 10.1074/jbc.M702390200. PubMed DOI PMC

Michalopoulos GK. Liver regeneration. J Cell Physiol. 2007;213:286–300. doi: 10.1002/jcp.21172. PubMed DOI PMC

Selzner M, Clavien PA. Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway. Hepatology. 2000;31:35–42. doi: 10.1002/hep.510310108. PubMed DOI

Murata H, Yagi T, Iwagaki H, et al. Mechanism of impaired regeneration of fatty liver in mouse partial hepatectomy model. J Gastroenterol Hepatol. 2007;22:2173–2180. doi: 10.1111/j.1440-1746.2006.04798.x. PubMed DOI

Hissin PJ, Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem. 1976;74:214–226. doi: 10.1016/0003-2697(76)90326-2. PubMed DOI

Roušar T, Kučera O, Lotková H, Cervinková Z. Assessment of reduced glutathione: comparison of an optimized fluorometric assay with enzymatic recycling method. Anal Biochem. 2012;423:236–240. doi: 10.1016/j.ab.2012.01.030. PubMed DOI

Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem. 1976;72:248–254. doi: 10.1016/0003-2697(76)90527-3. PubMed DOI

Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–358. doi: 10.1016/0003-2697(79)90738-3. PubMed DOI

Liu D, Li C, Chen Y, et al. Nuclear import of proinflammatory transcription factors is required for massive liver apoptosis induced by bacterial lipopolysaccharide. J Biol Chem. 2004;279:48434–48442. doi: 10.1074/jbc.M407190200. PubMed DOI

Seifrtová M, Havelek R, Cmielová J, et al. The response of human ectomesenchymal dental pulp stem cells to cisplatin treatment. Int Endod J. 2012;45:401–412. doi: 10.1111/j.1365-2591.2011.01990.x. PubMed DOI

Hirsova P, Kolouchova G, Dolezelova E, et al. Epigallocatechin gallate enhances biliary cholesterol secretion in healthy rats and lowers plasma and liver cholesterol in ethinylestradiol-treated rats. Eur J Pharmacol. 2012;691:38–45. doi: 10.1016/j.ejphar.2012.06.034. PubMed DOI

Seabra AL, Savassi-Rocha PR, Vasconcelos AC, Lima AS, Rodrigues KC, Almeida HM. Ischemia/reperfusion injury after continuous or intermittent hepatic pedicle clamping in rabbits. Arq Bras Cir Dig. 2012;25:105–109. doi: 10.1590/S0102-67202012000200009. PubMed DOI

Bader A, Pavlica S, Deiwick A, et al. Proteomic analysis to display the effect of low doses of erythropoietin on rat liver regeneration. Life Sci. 2011;89:827–833. doi: 10.1016/j.lfs.2011.08.002. PubMed DOI

Murray AB, Strecker W, Silz S. Ultrastructural changes in rat hepatocytes after partial hepatectomy, and comparison with biochemical results. J Cell Sci. 1981;50:433–448. PubMed

Shen G, Xu C, Hu R, et al. Comparison of (−)-epigallocatechin-3-gallate elicited liver and small intestine gene expression profiles between C57BL/6 J mice and C57BL/6 J/Nrf2 (−/−) mice. Pharm Res. 2005;22:1805–1820. doi: 10.1007/s11095-005-7546-8. PubMed DOI

Singh BN, Shankar S, Srivastava RK. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol. 2011;82:1807–1821. doi: 10.1016/j.bcp.2011.07.093. PubMed DOI PMC

Yang CS, Wang X. Green tea and cancer prevention. Nutr Cancer. 2010;62:931–937. doi: 10.1080/01635581.2010.509536. PubMed DOI

Yang F, de Villiers WJ, McClain CJ, Varilek GW. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J Nutr. 1998;128:2334–2340. PubMed

Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci USA. 1997;94:1441–1446. doi: 10.1073/pnas.94.4.1441. PubMed DOI PMC

Michalopoulos GK. Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol. 2010;176:2–13. doi: 10.2353/ajpath.2010.090675. PubMed DOI PMC

Smith DM, Wang Z, Kazi A, Li LH, Chan TH, Dou QP. Synthetic analogs of green tea polyphenols as proteasome inhibitors. Mol Med. 2002;8:382–392. PubMed PMC

Gupta S, Hastak K, Afaq F, Ahmad N, Mukhtar H. Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis. Oncogene. 2004;23:2507–2522. doi: 10.1038/sj.onc.1207353. PubMed DOI

Roy AM, Baliga MS, Katiyar SK. Epigallocatechin-3-gallate induces apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation. Mol Cancer Ther. 2005;4:81–90. PubMed

Shankar S, Suthakar G, Srivastava RK. Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer. Front Biosci. 2007;12:5039–5051. doi: 10.2741/2446. PubMed DOI

Kagaya N, Tagawa Y, Nagashima H, Saijo R, Kawase M, Yagi K. Suppression of cytotoxin-induced cell death in isolated hepatocytes by tea catechins. Eur J Pharmacol. 2002;450:231–236. doi: 10.1016/S0014-2999(02)02157-X. PubMed DOI

Wang Y, Mei Y, Feng D, Xu L. (−)-Epigallocatechin-3-gallate protects mice from concanavalin A-induced hepatitis through suppressing immune-mediated liver injury. Clin Exp Immunol. 2006;145:485–492. doi: 10.1111/j.1365-2249.2006.03137.x. PubMed DOI PMC

Katunuma N, Murata E, Le QT, Hayashi Y, Ohashi A. New apoptosis cascade mediated by lysosomal enzyme and its protection by epigallo-catechin gallate. Adv Enzyme Regul. 2004;44:1–10. doi: 10.1016/j.advenzreg.2003.11.016. PubMed DOI

Tzung SP, Fausto N, Hockenbery DM. Expression of Bcl-2 family during liver regeneration and identification of Bcl-x as a delayed early response gene. Am J Pathol. 1997;150:1985–1995. PubMed PMC

Gupta S, Hussain T, Mukhtar H. Molecular pathway for (−)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys. 2003;410:177–185. doi: 10.1016/S0003-9861(02)00668-9. PubMed DOI

Liang YC, Lin-Shiau SY, Chen CF, Lin JK. Inhibition of cyclindependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (−)-epigallocatechin-3-gallate. J Cell Biochem. 1999;75:1–12. doi: 10.1002/(SICI)1097-4644(19991001)75:1<1::AID-JCB1>3.0.CO;2-N. PubMed DOI

Hastak K, Gupta S, Ahmad N, Agarwal MK, Agarwal ML, Mukhtar H. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene. 2003;22:4851–4859. doi: 10.1038/sj.onc.1206708. PubMed DOI

Yang F, Oz HS, Barve S, de Villiers WJ, McClain CJ, Varilek GW. The green tea polyphenol (−)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Mol Pharmacol. 2001;60:528–533. PubMed

Wu CC, Hsu MC, Hsieh CW, Lin JB, Lai PH, Wung BS. Upregulation of heme oxygenase-1 by epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways. Life Sci. 2006;78:2889–2897. doi: 10.1016/j.lfs.2005.11.013. PubMed DOI

Sahin K, Tuzcu M, Gencoglu H, et al. Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. Life Sci. 2010;87:240–245. doi: 10.1016/j.lfs.2010.06.014. PubMed DOI

Park JH, Jin JY, Baek WK, et al. Ambivalent role of gallated catechins in glucose tolerance in humans: a novel insight into non-absorbable gallated catechin-derived inhibitors of glucose absorption. J Physiol Pharmacol. 2009;60:101–109. PubMed

Yao XM, Zhao J, Li Y, Li Y. Effects of bicyclol on liver regeneration after partial hepatectomy in rats. Dig Dis Sci. 2009;54:774–781. doi: 10.1007/s10620-009-0715-6. PubMed DOI

Kirimlioglu H, Ecevit A, Yilmaz S, Kirimlioglu V, Karabulut AB. Effect of resveratrol and melatonin on oxidative stress enzymes, regeneration, and hepatocyte ultrastructure in rats subjected to 70% partial hepatectomy. Transpl Proc. 2008;40:285–289. doi: 10.1016/j.transproceed.2007.11.050. PubMed DOI

Seehofer D, Schirmeier A, Bengmark S, et al. Inhibitory effect of curcumin on early liver regeneration following partial hepatectomy in rats. J Surg Res. 2009;155:195–200. doi: 10.1016/j.jss.2008.09.011. PubMed DOI

Kohoutek L, Cervinková Z, Kucera O, et al. Effect of S-adenosylmethionine on liver regeneration induced by partial hepatectomy. Gen Physiol Biophys. 2010;29:72–78. doi: 10.4149/gpb_2010_01_78. PubMed DOI

Liu YX, Jin LM, Zhou L. Sirolimus attenuates reduced-size liver ischemia–reperfusion injury but impairs liver regeneration in rats. Dig Dis Sci. 2010;55:2255–2262. doi: 10.1007/s10620-009-1002-2. PubMed DOI

Isbrucker RA, Edwards JA, Wolz E, Davidovich A, Bausch J. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies. Food Chem Toxicol. 2006;44:636–650. doi: 10.1016/j.fct.2005.11.003. PubMed DOI

Lambert JD, Kennett MJ, Sang S, Reuhl KR, Ju J, Yang CS. Hepatotoxicity of high oral dose (−)-epigallocatechin-3-gallate in mice. Food Chem Toxicol. 2010;48:409–416. doi: 10.1016/j.fct.2009.10.030. PubMed DOI PMC

Navarro VJ, Bonkovsky HL, Hwang SI, Vega M, Barnhart H, Serrano J. Catechins in dietary supplements and hepatotoxicity. Dig Dis Sci. 2013;58:2682–2690 . doi:10.1007/s10620-013-2687-9. PubMed PMC

Molinari M, Watt KD, Kruszyna T, et al. Acute liver failure induced by green tea extracts: case report and review of the literature. Liver Transpl. 2006;12:1892–1895. doi: 10.1002/lt.21021. PubMed DOI

Mazzanti G, Menniti-Ippolito F, Moro PA, Cassetti F, Raschetti R, Santuccio C, Mastrangelo S. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol. 2009;65:331–341. doi: 10.1007/s00228-008-0610-7. PubMed DOI

Chen GC, Ramanathan VS, Law D, et al. Acute liver injury induced by weight-loss herbal supplements. World J Hepatol. 2010;2:410–415. doi: 10.4254/wjh.v2.i11.410. PubMed DOI PMC

Shim M, Saab S. Severe hepatotoxicity due to hydroxycut: a case report. Dig Dis Sci. 2009;54:406–408. doi: 10.1007/s10620-008-0353-4. PubMed DOI

Schönthal AH. Adverse effects of concentrated green tea extracts. Mol Nutr Food Res. 2011;55:874–885. doi: 10.1002/mnfr.201000644. PubMed DOI

Galati G, Lin A, Sultan AM, O’Brien PJ. Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins. Free Radic Biol Med. 2006;40:570–580. doi: 10.1016/j.freeradbiomed.2005.09.014. PubMed DOI

Hirsova P, Karlasova G, Dolezelova E, et al. Cholestatic effect of epigallocatechin gallate in rats is mediated via decreased expression of Mrp2. Toxicology. 2013;303:9–15. doi: 10.1016/j.tox.2012.10.018. PubMed DOI

Ullmann U, Haller J, Decourt JP, et al. A single ascending dose study of epigallocatechin gallate in healthy volunteers. J Int Med Res. 2003;31:88–101. doi: 10.1177/147323000303100205. PubMed DOI

Mereles D, Hunstein W. Epigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises? Int J Mol Sci. 2011;12:5592–5603. doi: 10.3390/ijms12095592. PubMed DOI PMC

In vitro toxicity of epigallocatechin gallate in rat liver mitochondria and hepatocytes